Literature DB >> 2179725

Diabetic retinopathy. A synthesis of perspectives.

T J Merimee1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2179725     DOI： 10.1056/NEJM199004053221406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  Neurochemical correlates of alloxan diabetes: glucose and related brain metabolism in the rat.

Authors:  Nayeemunnisa Ahmed; Noor Zahra
Journal:  Neurochem Res       Date:  2010-12-29       Impact factor: 3.996

2.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  An in vitro model of diabetes.

Authors:  S L Atkin; E A Masson; D Wilcox
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996 Jul-Aug       Impact factor: 2.416

Review 4.  Prevention of ischemic stroke.

Authors:  Jesse Weinberger
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

5.  Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats.

Authors:  Xiaoping Yu; Zhaoxia Xu; Mantian Mi; Hongxia Xu; Jundong Zhu; Na Wei; Ka Chen; Qianyong Zhang; Kaihong Zeng; Jian Wang; Fang Chen; Yong Tang
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

6.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

7.  Hemorheological disorders in diabetes mellitus.

Authors:  Young I Cho; Michael P Mooney; Daniel J Cho
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry.

Authors:  N H Schut; E C van Arkel; M R Hardeman; H J Bilo; R P Michels; J Vreeken
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy.

Authors:  A Tromp; J M Hooymans; B C Barendsen; J J van Doormaal
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.